Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA 6

Nature

Volumn 548, Issue 7667, 2017, Pages 356-360

  Taniguchi, Reiya ^a,b   Inoue, Asuka ^c,d   Sayama, Misa ^e   Uwamizu, Akiharu ^c   Yamashita, Keitaro ^f   Hirata, Kunio ^d,f   Yoshida, Masahito ^g   Tanaka, Yoshiki ^d   Kato, Hideaki E ^a,b   Nakada Nakura, Yoshiko ^c   Otani, Yuko ^e   Nishizawa, Tomohiro ^a,b,d   Doi, Takayuki ^g   Ohwada, Tomohiko ^e   Ishitani, Ryuichiro ^a,b   Aoki, Junken ^a,c   Nureki, Osamu ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b RIKEN   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e RIKEN Harima Institute Research   (Japan)

^f NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^g KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHOLIPID;

ALOPECIA; ANIMAL; BINDING SITE; CELL MEMBRANE; CHEMISTRY; ENZYME SPECIFICITY; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; MOLECULAR DOCKING; MUTAGENESIS; PHYLOGENY; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; X RAY CRYSTALLOGRAPHY; ZEBRA FISH;

ALOPECIA; ANIMALS; BINDING SITES; CELL MEMBRANE; CRYSTALLOGRAPHY, X-RAY; HEK293 CELLS; HUMANS; LIGANDS; LYSOPHOSPHOLIPIDS; MOLECULAR DOCKING SIMULATION; MUTAGENESIS; PHYLOGENY; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, LYSOPHOSPHATIDIC ACID; SUBSTRATE SPECIFICITY; ZEBRAFISH;

EID: 85027844480     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature23448     Document Type: Article

References (50)

1. Kihara, Y., Maceyka, M., Spiegel, S., Chun, J. Lysophospholipid receptor nomenclature review: IUPHAR Review 8. Br. J. Pharmacol. 171, 3575-3594 (2014).
2. Mills, G. B., Moolenaar, W. H. The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 3, 582-591 (2003).
3. Tager, A. M. et al. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat. Med. 14, 45-54 (2008).
4. Yanagida, K., Kurikawa, Y., Shimizu, T., Ishii, S. Current progress in non-Edg family LPA receptor research. Biochim. Biophys. Acta 1831, 33-41 (2013).
5. Chrencik, J. E. et al. Crystal structure of antagonist bound human lysophosphatidic acid receptor 1. Cell 161, 1633-1643 (2015).
6. Zhang, K. et al. Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature 509, 115-118 (2014).
7. Zhang, J. et al. Agonist-bound structure of the human P2Y12 receptor. Nature 509, 119-122 (2014).
8. Zhang, D. et al. Two disparate ligand-binding sites in the human P2Y1 receptor. Nature 520, 317-321 (2015).
9. Pasternack, S. M. et al. G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nat. Genet. 40, 329-334 (2008).
10. Shimomura, Y. et al. Disruption of P2RY5, an orphan G protein-coupled receptor, underlies autosomal recessive woolly hair. Nat. Genet. 40, 335-339 (2008).
11. Khandoga, A. L., Pandey, D., Welsch, U., Brandl, R., Siess, W. GPR92/LPA5 lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques. Cardiovasc. Res. 90, 157-164 (2011).
12. Sumida, H. et al. LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis. Blood 116, 5060-5070 (2010).
13. Igarashi, H., Akahoshi, N., Ohto-Nakanishi, T., Yasuda, D., Ishii, S. The lysophosphatidic acid receptor LPA4 regulates hematopoiesis-supporting activity of bone marrow stromal cells. Sci. Rep. 5, 11410 (2015).
14. Lin, M.-E., Rivera, R. R., Chun, J. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain. J. Biol. Chem. 287, 17608-17617 (2012).
15. Yanagida, K. et al. Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6. J. Biol. Chem. 284, 17731-17741 (2009).
16. Lee, M. et al. P2Y5 is a G i, G 12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion. Am. J. Physiol. Gastrointest. Liver Physiol. 297, G641-G654 (2009).
17. Inoue, A. et al. LPA-producing enzyme PA-PLA1 regulates hair follicle development by modulating EGFR signalling. EMBO J. 30, 4248-4260 (2011).
18. Kazantseva, A. et al. Human hair growth deficiency is linked to a genetic defect in the phospholipase gene LIPH. Science 314, 982-985 (2006).
19. Ketscher, A. et al. LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6. Oncogenesis 3, e120 (2014).
20. Inoue, A. et al. TGF shedding assay: An accurate and versatile method for detecting GPCR activation. Nat. Methods 9, 1021-1029 (2012).
21. Caffrey, M., Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nat. Protocols 4, 706-731 (2009).
22. Zhang, C. et al. High-resolution crystal structure of human protease-activated receptor 1. Nature 492, 387-392 (2012).
23. Jiang, G., Inoue, A., Aoki, J., Prestwich, G. D. Phosphorothioate analogs of sn-2 radyl lysophosphatidic acid (LPA): Metabolically stabilized LPA receptor agonists. Bioorg. Med. Chem. Lett. 23, 1865-1869 (2013).
24. Kruse, A. C. et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature 504, 101-106 (2013).
25. Shihoya, W. et al. Activation mechanism of endothelin ETB receptor by endothelin-1. Nature 537, 363-368 (2016).
26. Nishimasu, H. et al. Crystal structure of autotaxin and insight into GPCR activation by lipid mediators. Nat. Struct. Mol. Biol. 18, 205-212 (2011).
27. Sonoda, H. et al. A novel phosphatidic acid-selective phospholipase A1 that produces lysophosphatidic acid. J. Biol. Chem. 277, 34254-34263 (2002).
28. Dranoff, J. A. et al. A primitive ATP receptor from the little skate Raja erinacea. J. Biol. Chem. 275, 30701-30706 (2000).
29. Hanson, M. A. et al. Crystal structure of a lipid G protein-coupled receptor. Science 335, 851-855 (2012).
30. Cherezov, V. et al. High-resolution crystal structure of an engineered human 2-adrenergic G protein-coupled receptor. Science 318, 1258-1265 (2007).
31. Hirata, K. et al. Achievement of protein micro-crystallography at SPring-8 beamline BL32XU. J. Phys. Conf. Ser. 425, 12002 (2013).
32. Ueno, G. et al. Remote access and automation of SPring-8 MX beamlines. AIP Conf. Proc. 1741, 50021 (2016).
33. Kabsch, W. XDS. Acta Crystallogr. D 66, 125-132 (2010).
34. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674 (2007).
35. Vagin, A. A. et al. REFMAC5 dictionary: Organization of prior chemical knowledge and guidelines for its use. Acta Crystallogr. D 60, 2184-2195 (2004).
36. Adams, P. D. et al. PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213-221 (2010).
37. Emsley, P., Lohkamp, B., Scott, W. G., Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486-501 (2010).
38. Šali, A., Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779-815 (1993).
39. Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., Sherman, W. Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27, 221-234 (2013).
40. Olsson, M. H. M., Søndergaard, C. R., Rostkowski, M., Jensen, J. H. PROPKA3: Consistent treatment of internal and surface residues in empirical pKa predictions. J. Chem. Theory Comput. 7, 525-537 (2011).
41. Friesner, R. A. et al. Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47, 1739-1749 (2004).
42. Halgren, T. A. et al. Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J. Med. Chem. 47, 1750-1759 (2004).
43. Halgren, T. New method for fast and accurate binding-site identification and analysis. Chem. Biol. Drug Des. 69, 146-148 (2007).
44. Bowers, K. J. et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. Proc. 2006 ACM/IEEE Conf. Supercomputing (SC06) http://dx.doi.org/10.1145/1188455.1188544 (Tampa, Florida, 11-17 November 2006).
45. Essmann, U. et al. A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577 (1995).
46. Okudaira, M. et al. Separation and quantification of 2-acyl-1-lysophospholipids and 1-acyl-2-lysophospholipids in biological samples by LC-MS/MS. J. Lipid Res. 55, 2178-2192 (2014).
47. Hayashi, R., Inoue, A., Suga, Y., Aoki, J., Shimomura, Y. Analysis of unique mutations in the LPAR6 gene identified in a Japanese family with autosomal recessive woolly hair/hypotrichosis: Establishment of a useful assay system for LPA6. J. Dermatol. Sci. 78, 197-205 (2015).
48. Devost, D. et al. Conformational profiling of the AT1 angiotensin II receptor reflects biased agonism, G protein coupling, and cellular context. J. Biol. Chem. 292, 5443-5456 (2017).
49. Ehlert, F. J., Griffin, M. T., Sawyer, G. W., Bailon, R. A simple method for estimation of agonist activity at receptor subtypes: Comparison of native and cloned M3 muscarinic receptors in guinea pig ileum and transfected cells. J. Pharmacol. Exp. Ther. 289, 981-992 (1999).
50. Hattori, M., Hibbs, R. E., Gouaux, E. A fluorescence-detection size-exclusion chromatography-based thermostability assay for membrane protein precrystallization screening. Structure 20, 1293-1299 (2012).